Live Breaking News & Updates on கேய்ட் அக்வா

Stay updated with breaking news from கேய்ட் அக்வா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA


Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA
Share Article
Validcare s Decentralized Clinical Trial Allows for Consumer Participation During COVID
We are excited to have our state of the art, decentralized trial technology overcome the hurdles of performing research during a pandemic.
DENVER (PRWEB)
April 15, 2021
Validcare announced today the addition of a second cohort of CBD brands participating in a large scale, human safety study, a significant and widescale endeavor to answer the FDA’s call for additional safety data. This second cohort expands the reliability of Validcare’s recently completed findings in Cohort 1 regarding liver safety in healthy adults ingesting either full or broad-spectrum hemp-derived CBD. The study is designed to respond to the FDA’s repeated requests, including the Agency’s March 5, 2020 report to Congress ....

United States , Patrick Mccarthy , Jeff Lombardo Pharm , Dave Neundorfer , Tauriga Sciences Inc , Impact Naturals , Tauriga Sciences , Keith Aqua , Open Book , Asterra Labs , Columbia Care , Global Widget , Jeff Lombardo Pharmd , Press Release , ஒன்றுபட்டது மாநிலங்களில் , பேட்ரிக் ம்க்கார்தீ , ஜெஃப் லோம்பார்டோ பார்ம் , கேய்ட் அக்வா , திறந்த நூல் , கொலம்பியா பராமரிப்பு , உலகளாவிய விட்ஜெட் , ஜெஃப் லோம்பார்டோ பர்ம்த் , ப்ரெஸ் வெளியீடு ,

Study: No evidence of liver toxicity from use of CBD from hemp


Study: No evidence of liver toxicity from use of CBD from hemp
Investigators report to FDA no evidence of liver toxicity in 839 adults consuming oral CBD
Published: 
Updated: 
Tags: 
CBD products
Researchers presented initial results from a study to the FDA in March suggesting there is no evidence of liver disease from the use of hemp-derived CBD products.
The study, conducted by a team from clinical research company Validcare, aims to help the FDA to determine how to appropriately regulate CBD products.
CBD, short for cannabidiol, comes from the cannabis plant. It is one of two most commonly known compounds of cannabis (marijuana), the other being delta-9-tetrahydrocannabinol (THC). It’s the THC that is associated with a “high,” not CBD. ....

United States , Patrick Mccarthy , Jeff Lombardo Pharm , Lennox Gastaut , Michigan Department Of Licensing , Michigan Department Of Agriculture , Regulatory Affairs , Drug Administration , Marijuana Regulatory Agency , Industrial Hemp Research , Michigan Marijuana Regulatory Agency , Rural Development , Jeff Lombardo Pharmd , Keith Aqua , Michigan Department , Development Act , Generally Regarded As Safe , Michigan Food Law , ஒன்றுபட்டது மாநிலங்களில் , பேட்ரிக் ம்க்கார்தீ , ஜெஃப் லோம்பார்டோ பார்ம் , மிச்சிகன் துறை ஆஃப் உரிமம் , ஒழுங்குமுறை வாழ்க்கைத்தொழில்கள் , தொழில்துறை சணல் ஆராய்ச்சி , கிராமப்புற வளர்ச்சி , ஜெஃப் லோம்பார்டோ பர்ம்த் ,